DE

David Epstein

Past Chief Executive Officer Seagen

Delray Beach, Florida

Investor
VC

Invests in

Stages:

Seed
Series A

Locations:

Florida

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Pharmaceutical Industry
Oncology
Biotechnology
Healthcare
Leadership
Global Leadership
Clinical Development
Clinical Trials
Drug Development
Cardiology
Global Marketing
Infectious Diseases
Commercialization
Biopharmaceuticals
Diabetes
Strategy
Cross-functional Team Leadership
Venture Capital
deal making

Education

Work Experience

Agomab

2024

  • Chairman

    2024

Tempus AI

2024

  • Board Member

    2024

PELICAN HARBOR SEABIRD STATION INC

2020

  • Board Member

    2020

Valo

2019

  • Board Member

    2019

Remedii LLC

2016

  • Managing General Partner

    2016

    Consulting and Board Services

Seagen

2022 - 2023

  • Chief Executive Officer

    2022 - 2023

    Company sold

Cellestia Biotech

2022 - 2023

  • Independent Director

    2022 - 2023

Woolsey Pharma

2020 - 2023

  • Independent Director

    2020 - 2023

Evelo Biosciences

2018 - 2023

  • Independent Director

    2018 - 2023

    Chairman until June 2022

Ring Therapeutics

2021 - 2022

  • Independent Director

    2021 - 2022